Advertisement
Screener

ALIGN TECHNOLOGY, INC. (ALGN) Overview

ALIGN TECHNOLOGY, INC. (ALGN) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual 1.51; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual 1.57; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual 0.78; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual 1.72; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$125.67$138.91$153.55$169.73$187.61$207.392025-11-062026-11-06$118.64$171.39$247.60$357.71$516.77$746.572021-11-082026-11-06$83.47$130.05$202.63$315.71$491.90$766.422016-11-072026-11-06$4.75$13.13$36.29$100.31$277.27$766.422006-11-062026-11-06$1.23$4.47$16.17$58.53$211.79$766.422001-01-302026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$166.04
Previous close
$144.01
Change
$22.04
Change (%)
15.30%
Close date
2026-11-06
Previous close date
2026-09-29
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

ALGN
-7.77%
S&P 500
(m)

1 year

ALGN
+13.96%
S&P 500
(m)

3 years

ALGN
-52.83%
S&P 500
(m)

5 years

ALGN
-78.60%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual 1.51

0.701.001.301.601.9031 Mar 2025: estimate (m); actual 1.2731 Mar 2025(m)30 Jun 2025: estimate (m); actual 1.7230 Jun 2025(m)30 Sept 2025: estimate (m); actual 0.7830 Sept 2025(m)31 Mar 2026: estimate (m); actual 1.5731 Mar 2026(m)30 Jun 2026: estimate (m); actual 1.5130 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)1.51(m)(m)
1 Jan 202631 Mar 2026(m)1.57(m)(m)
1 Jul 202530 Sept 2025(m)0.78(m)(m)
1 Apr 202530 Jun 2025(m)1.72(m)(m)
1 Jan 202531 Mar 2025(m)1.27(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual 5.65

4.535.877.208.549.8731 Dec 2021: estimate (m); actual 9.6931 Dec 2021(m)31 Dec 2022: estimate (m); actual 4.6131 Dec 2022(m)31 Dec 2023: estimate (m); actual 5.8131 Dec 2023(m)31 Dec 2024: estimate (m); actual 5.6231 Dec 2024(m)31 Dec 2025: estimate (m); actual 5.6531 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)5.65(m)(m)
1 Jan 202431 Dec 2024(m)5.62(m)(m)
1 Jan 202331 Dec 2023(m)5.81(m)(m)
1 Jan 202231 Dec 2022(m)4.61(m)(m)
1 Jan 202131 Dec 2021(m)9.69(m)(m)

Revenue vs. Earnings

USD

30 Jun 2026 ■ Revenue 1.06B ■ Earnings 0.11B — Profit margin 10.25%

-0.13B4.7%0.31B7.8%0.75B10.9%1.18B13.9%30 Sept 2025: revenue 1.00B; earnings 0.06B; profit margin 5.70%30 Sept 202531 Dec 2025: revenue 1.05B*; earnings 0.14B*; profit margin 12.93%*; Revenue: Annual amount − nine-month amount; Earnings: Annual amount − nine-month amount; period 2025-10-01 to 2025-12-31; USD.31 Dec 202531 Mar 2026: revenue 1.04B; earnings 0.11B; profit margin 10.84%31 Mar 202630 Jun 2026: revenue 1.06B; earnings 0.11B; profit margin 10.25%30 Jun 2026

31 Dec 2025 ■ Revenue 4.03B ■ Earnings 0.41B — Profit margin 10.16%

-0.48B8.7%1.18B10.0%2.85B11.2%4.52B12.5%31 Dec 2022: revenue 3.73B; earnings 0.36B; profit margin 9.69%31 Dec 202231 Dec 2023: revenue 3.86B; earnings 0.45B; profit margin 11.52%31 Dec 202331 Dec 2024: revenue 4.00B; earnings 0.42B; profit margin 10.53%31 Dec 202431 Dec 2025: revenue 4.03B; earnings 0.41B; profit margin 10.16%31 Dec 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$166.04(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$166.04High(m)Average(m)Low(m)2025-11-062026-11-06

Recent news

View more →

(m)

YouTube videos mentioning ALGN

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending 30 Jun 2026.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$413.23M
Profit margin
9.98%
Return on assets · 12 month
6.54%
Index membership
(m)
Employees
20.29K
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
900.41K
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
-6.05%*
Total return · month
-8.61%*
Total return · quarter
-16.96%*
Total return · half year
-13.45%*
Total return · year to date
-7.77%*
Total return · 1 year
13.96%*
Total return · 3 years
-52.83%*
Total return · 5 years
-78.60%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$4.14B
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

ALIGN TECHNOLOGY, INC. Overview

View more →

(m)

(m)

SEC CIK
1097149
Industry (SIC)
3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies
Country of operation
United States
Business address
410 NORTH SCOTTSDALE ROAD, SUITE 1300, TEMPE, Arizona, 85288, United States
Fiscal year end
1231
Phone
408-470-1000

Similar stocks

Stock NameCountryMarket CapPE Ratio
MSA Safety Inc (MSA)United States$7.023B21.47
ZIMMER BIOMET HOLDINGS, INC. (ZBH)United States$17.103B20.66
ESTABLISHMENT LABS HOLDINGS INC. (ESTA)$1.954B-65.76
Cadre Holdings, Inc. (CDRE)United States$1.123B33.88
Enovis CORP (ENOV)United States$1.053B-1.18
Anteris Technologies Global Corp. (AVR)United States$0.746B
STERIS plc (STE)Ireland$20.343B25.49
Sanara MedTech Inc. (SMTI)United States$0.323B-6.81
Inogen Inc (INGN)United States$0.139B-7.00
Conexeu Sciences Inc. (CNXU)United States$0.111B